Power And Sample Size Considerations In A Pre-Maturely Terminated Randomized, Double-Mask, Placebo-Controlled, Dose-Response, Phase 2 Study Of The Safety And Efficacy Of Thymosin Beta 4 For The Treatment Of Persistent Corneal Epithelial Defects Resulting